| Current Price | $640.63 | Mkt Cap | $65.0B |
|---|---|---|---|
| Open | $648.00 | P/E Ratio | 30.74 |
| Prev. Close | $640.34 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $629.00 - $655.93 | Volume | 1,003,947 |
| 52-Wk Range | $271.37 - $653.53 | Avg. Daily Vol. | 1,536,190 |
The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.
| Current Price | $640.63 | Mkt Cap | $65.0B |
|---|---|---|---|
| Open | $648.00 | P/E Ratio | 30.74 |
| Prev. Close | $640.34 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $629.00 - $655.93 | Volume | 1,003,947 |
| 52-Wk Range | $271.37 - $653.53 | Avg. Daily Vol. | 1,536,190 |
The best Bull and Bear pitches based on recency and number of recommendations.
REGN has a pipeline of potential biotech products.
$9.7B? Lots of obstacles, including Lucentis, Avastin, payers, etc., and the market is acting like they've already hit huge numbers. Strange self-limiting value prop on this, they had to develop it based on decreased injection frequency rather than… More
Read the most recent pitches from players about REGN.
Recs
JaxPicks
(67.29)
Submitted: 4/23/2020 12:07:16 PM :
Start Price:
$569.78
NASDAQ:REGN Score:
+1.24
Pharma co. with good growth at reasonable p/e with high GM and ROIC.
Recs
TMFAdriaCimino
(55.74)
Submitted: 4/16/2020 6:05:29 AM :
Start Price:
$525.30
NASDAQ:REGN Score:
+9.38
A blockbuster drug for macular degeneration and collaborations with big pharma companies make this company one that could deliver revenue into the future.
Recs
TMFBigFrog
(69.90)
Submitted: 6/9/2019 3:07:03 PM :
Start Price:
$305.11
NASDAQ:REGN Score:
+101.38
Longer run opportunity looks stronger than today's valuation.
Find the members with the highest scoring picks in REGN.
oneisthelonelies (< 20) Score: +4,298.04
The Score Leader is the player with the highest score across all their picks in REGN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| oneisthelonelies | < 20 | 8/6/2007 |
|
5Y | $14.15 | +4,427.42% | +129.38% | +4,298.04 | 0 Comment | |
| DNAdivaSTL | 51.07 | 7/8/2008 |
|
NS | $14.30 | +4,379.93% | +159.27% | +4,220.66 | 0 Comment | |
| kiranmn | < 20 | 5/27/2009 |
|
3Y | $14.49 | +4,321.19% | +247.25% | +4,073.94 | 0 Comment | |
| Grinnell4Eva | < 20 | 6/6/2008 |
|
1Y | $14.88 | +4,205.31% | +138.28% | +4,067.03 | 0 Comment | |
| stlb1ues | 67.27 | 6/26/2008 |
|
1Y | $14.96 | +4,182.29% | +148.33% | +4,033.96 | 0 Comment | |
| mpearson29 | 76.89 | 11/25/2008 |
|
NS | $14.74 | +4,246.20% | +269.00% | +3,977.20 | 0 Comment | |
| giffman62 | < 20 | 6/6/2008 |
|
NS | $15.22 | +4,109.13% | +132.09% | +3,977.05 | 1 Comment | |
| Pmccorm | 94.88 | 6/5/2008 |
|
3Y | $15.28 | +4,092.60% | +133.38% | +3,959.22 | 0 Comment | |
| benes27 | 69.75 | 6/5/2008 |
|
3M | $15.28 | +4,092.60% | +133.43% | +3,959.17 | 0 Comment | |
| UncleSmitty | 55.27 | 7/14/2008 |
|
NS | $15.24 | +4,103.61% | +158.59% | +3,945.02 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
